The time is now to make your plans for
#ACR24
in Washington, D.C., Nov. 14-19! Early registration opens in June, but don’t miss any news & updates—join our preregistration email list today →
The ACR is aware of the emerging concerns surrounding access to needed treatments such as
#MTX
after the recent decision in Dobbs v. Jackson Women’s Health Organization.
The Distinguished Global Public Health Award is granted for leadership & exemplary contributions to the global community. The ACR Board of Directors wishes to honor Anthony S. Fauci, MD, for his commitment to preserve public health in the setting of the
#COVID19
pandemic.
#ACR20
The ACR has developed new guidance for
#rheumatology
providers on the use of the
#COVID19
vaccines for patients with rheumatic & musculoskeletal diseases. Details →
#ACR23
was a success! We welcomed over 13,000 attendees from nearly 100 countries, including 400 attendees from developing countries. Thank you for helping us share knowledge with colleagues around the world. See you at
#ACR24
!
The ACR has assembled a task force of medical & policy experts to determine the best course of action for ensuring our patients keep access to treatments they need.
IMPORTANT STATEMENT FROM THE ACR: "The American College of Rheumatology acknowledges President Trump's directive to the Food and Drug Administration asking them to 'fast track' potential treatments for COVID-19, including the antimalarials chloroquine and hydroxychloroquine.
#ACR20
is going virtual! ACR Convergence 2020, the world’s premier virtual rheumatology experience, is happening online, Nov 5-9. We’ve given the ACR’s annual meeting a new name, a fresh look & kept the stellar education & networking you’d expect!
ACR Convergence 2023 is almost here! Great news—you still have time to register to experience the world’s premier
#rheum
meeting online, Nov. 10-15. Refresh the way you deliver care to your patients with new knowledge & inspiration from experts across the world. Join us →
Two days before ACR Convergence 2023 kickoff! There’s still time to secure your online registration for the best in
#rheum
education. Registration is open through Nov. 15 at noon ET. Planning to be in the area? On-site registration is also available. Join us →
Congratulations to Debashish Danda, MD, DM, FACR, FRCP, MBBS, recipient of the 2023 Distinguished International Rheumatology Professional Award!
@DandaDebashish
@OffCMCVellore
#ACR23
Congratulations to
@BharatKumarMD
, who will be serving as Physician Editor of The
#Rheumatologist
for the 2023–2027 term. Dr. Kumar’s first issue will be January 2023. Dr. Kumar is the Associate Director, Rheumatology Fellowship Program, Division of Immunology
@IntMedatIowa
.
The ACR is honored to announce 2 featured speakers for ACR Convergence: Dr. Eric Rubin,
@NEJM
editor-in-chief, and NIAID director Dr. Anthony Fauci!
#ACR20
On behalf of its members, the ACR wishes to express strong support for Dr. Anthony Fauci & his continued & close involvement in the work to address the nation’s response to the
#COVID19
pandemic. Read more →
or if any initial disruptions are potentially temporary & due to the independent actions of pharmacists trying to figure out what is & isn’t allowed where they practice.
We, the American College of Rheumatology (ACR), the European Alliance of Associations for Rheumatology (EULAR), and the International League of Associations for Rheumatology (ILAR) are deeply saddened by the passing of Debashish Danda, MBBS, MD, DM, FRCP. Professor Danda was a
The ACR is pleased to announce the recipients of the Phil Robinson Global Scholarship for
#ACR23
. The 2023 scholars are:
▪️ Becky Abdissa Adugna, MD, Addis Ababa University, Ethiopia
▪️ Rudrarpan Chattergee, MD, Sanjay Gandhi Postgraduate Institute of Medical Sciences, India
▪️
The ACR announces communication and data dissemination support of new
@UCSF
-hosted COVID-19 RedCap registry open to rheumatologists worldwide -more information to come
#covid4Rheum
We are deeply troubled by the recent events surrounding the death of George Floyd. This tragedy is the latest in a long history of senseless killings of people of color. Read our full statement
Congratulations to Ida Dzifa Dey, MD, FWACP, FGCP, MSc, SCE(RCP), recipient of the 2021 International Rheumatology Professional Award!
@UnivofGh
#ACR21
ALL-NEW EPISODE! In a
#scleroderma
research paper evaluating risks for cancer, what could be more important than the results? LISTEN HERE →
@ACR_Journals
Congratulations to Lisa Criscione-Schreiber, MD, MMed, recipient of the 2022 Distinguished Fellowship Program Director Award!
@LisaCriscione
@DukeMedSchool
#ACR22
ACR President Ellen Gravallese, MD -
"We are so impressed with this group's ability to organize so quickly and excited to see this initiative be realized. We are happy to support this important effort to help the global rheumatology community."
#covid4Rheum
The ARP Advanced Rheumatology Course is here! The comprehensive course or 19 individual activities can build your knowledge in the care of people with rheumatic disease. This is what you need to build your practical skills. Explore the course today →
For
#rheum
patients, the benefit of
#COVID19
vaccination outweighs any small, possible risks for new autoimmune reactions or disease flare. Learn more from the ACR's new COVID-19 Vaccine Clinical Guidance →
We are delighted to welcome the ACR-EULAR-APLAR Research Exchange scholars to the UC San Diego Altman Clinical and Translational Research Institute. A big thank you to all participants and the program host Dr. Gary Firestein! 🌏
@eular_org
@APLAR_org
@ucsdactri
#ACR23
We have released new recommendations titled "Guiding Principles from the American College of Rheumatology for Scarce Resource Allocation During the
#COVID19
Pandemic: The Case of
#Hydroxychloroquine
" to encourage balanced supply management.
#covid4rheum
Training the
#rheum
care team has never been easier! The ARP Fundamentals of Rheumatology (FRC) Course, featuring 10 cutting-edge, online learning activities, will hone your team’s diagnostic skills & expand their understanding of rheumatic disorders. BONUS: New ACR/ARP members &
The ACR salutes Jinoos Yazdany, MD, MPH, with
@ZSFGCare
for her leadership in the development & implementation of the
@rheum_covid
COVID-19 Rheumatology Registry →
#RheumChangeMaker
#PriorAuthorization
is a cumbersome process that requires physicians to obtain pre-approval for medical treatments or tests before rendering care to their patients. It’s time for Congress to
#FixPriorAuth
! Learn More at .
#RegReliefCoalition
#ACR20
on-demand recording now available – watch as Dr. Fauci expresses appreciation for the entire rheumatology community, accepts the ACR Distinguished Global Public Health Award & discusses the current state of the
#COVID19
pandemic →
The ACR &
@eular_org
have developed new antiphospholipid syndrome (APS) classification criteria, providing a strong foundation for future
#APS
research. View →
We have released an evidence-based, clinical guidance for the care of
#rheum
patients during the
#COVID19
pandemic. Recommendations address various treatment options and provide direction for when to start, stop, or reduce medications.
#COVID4rheums
The faster we get this populated with cases, the closer we'll get to unlocking some of the mysteries around
#COVID19
. Submit your cases today!
#covid4rheum
Healthcare providers:
If you have a patient with a rheumatologic condition (adult or pediatric) who has developed COVID-19, please report the case to our registry at
ACR releases updated clinical guidance for
#rheum
providers on the use of the
#COVID19
vaccines for patients with rheumatic & musculoskeletal diseases →
While we remain hopeful that hydroxychloroquine and chloroquine will be proven effective against
#COVID19
, we also need to ensure that rheumatology patients who depend on these medications have access to them during this crisis.
We are proud to be playing a supporting role in the COVID-19 Global Rheumatology Alliance and encourage participation in the registry to help the global effort to collect pertinent data on
#COVID19
infection in rheumatic disease patients.
#covid4rheum
If you are experiencing any drug shortage issues, please use this page to report them to the
@US_FDA
as they continue to work on supply chain management:
#COVID19
#hydroxychloroquine
#HCQ
Rheumatologists have extensive experience using these drugs and understand their safety and efficacy, including for our patients with rheumatic disease who take these medications on a regular basis. We hope that pragmatic clinical trials of these drugs can be done quickly...
We are looking forward to seeing you all in Chicago! Be sure to use the official Annual Meeting hashtag -
#ACR18
- (instead of
#ACR2018
) so everyone can see your tweets!
to determine how well they work, who should get them, and at what point in the illness. If the demand for these drugs increases rapidly, we urge pharmaceutical companies to continue to provide these medications to mitigate drug shortages."
#COVID19
The ACR is closely monitoring today’s CDC discussion on
#COVID19
#vaccination
now that the FDA has authorized an additional dose of the Pfizer & Moderna
#mRNA
#vaccines
for certain immunocompromised individuals under the current EUA.
The ACR salutes Arundathi Jayatilleke, MD, with
@TempleUniv
for her contributions as a core member of the
@rheum_covid
Clinical & Scientific Committee & her lead role in a multitude of projects →
#RheumChangeMaker
The ACR Global Engagement Committee is pleased to announce and congratulate the first cohort of ACR International Advisers:
▪️ Simone Appenzeller, MD, PhD (Brazil)
▪️ Haner Direskeneli, MD (Turkey)
▪️ David Liew, MBBS, FRACP (Australia)
▪️ Puja Mehta, MBBS, MD (UK)
▪️ Gaafar
The
#ACR20
Great Debate will feature two experts discussing whether
#JAK
inhibitors should be used before biologics if methotrexate fails. The session runs Friday, Nov. 6., from 10:00 to 11:00 AM ET. Learn more →
The ACR’s Annual Meeting Planning Committee was busy planning ACR Convergence 2023 this weekend—can’t wait to share what we have planned for you in San Diego in November!
#ACR23
#ACR23
abstracts now online! Browse nearly 2,600 abstracts representing the highest-impact research in the field of
#rheum
. NOTE: Information that goes beyond that contained in the abstract is under embargo until Nov. 7 at 10:00 AM ET. Browse →
Established to honor a founding member of
@rheum_covid
, colleague, friend, & leader in
#rheum
, the Phil Robinson Global Scholars Program provides scholarships to register for, travel to, & attend
#ACR24
in Washington, D.C. Must be an early career
#rheum
/trainee,
#rheum
Our COVID-19 Vaccine Clinical Guidance Task force is also meeting Monday, August 16. We will share details as soon as we know what this means for
#rheum
patients & providers.
BREAKING: ACR develops 2 new
#COVID19
clinical guidance docs for pediatric patients: care of children with pediatric rheumatic disease & mgmt of inflammatory syndromes in children with recent or concurrent infections with SARS-CoV-2. Details →
⚠️ALMOST FULL!⚠️Plan your weekend getaway to Chicago for
#SOTA24
, April 12-14, before space runs out. Join hundreds of your colleagues as they listen & learn from top experts about what’s on the horizon for the field of
#rheum
. Secure your seat NOW →
Not
The ACR will review its new guidance on
#COVID19
#vaccine
use in patients with rheumatic disease during a town hall on Feb. 16, 7:30–8:30 PM ET. Register today to reserve your spot & submit questions in advance →
#ACR20
is finally here and ACR Convergence Today is your go-to for meeting news, program highlights & coverage of popular sessions. Meeting attendees – watch your email daily for the latest stories. View →
Promises kept –
#ACR20
is where
#rheumatology
was able to collaborate, celebrate, innovate & learn. Thank you ACR Convergence 2020 volunteers & ACR staff for bringing the vision to life!
This week, more than 100 physicians, health professional leaders and patient advocates will be on Capitol Hill to urge lawmakers to act on a range of policy issues affecting patient access to care!
#Act4Arthritis